NASDAQ: VVOSVivos Therapeutics Inc Stock Ownership - Who owns Vivos Therapeutics?
Insider buying vs selling
Have Vivos Therapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when VVOS insiders and whales buy or sell their stock.
VVOS Shareholders
What type of owners hold Vivos Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Gurdev Dave Singh | 54.67% | 3,219,705 | $14.26M | Insider |
| Ronald Kirk Huntsman | 30.94% | 1,822,061 | $8.07M | Insider |
| Michael C. Skaff | 22.79% | 1,342,498 | $5.95M | Insider |
| Anson Funds Management LP | 4.12% | 242,583 | $1.07M | Institution |
| Geode Capital Management LLC | 0.97% | 57,349 | $254.06k | Institution |
| Cutter Co Brokerage Inc | 0.83% | 49,100 | $217.51k | Institution |
| Vanguard Group Inc | 0.72% | 42,634 | $188.87k | Institution |
| Envestnet Asset Management Inc | 0.66% | 38,873 | $172.21k | Institution |
| Commonwealth Equity Services LLC | 0.58% | 34,000 | $150.62k | Institution |
| Royal Bank Of Canada | 0.31% | 18,004 | $79.76k | Institution |
VVOS vs Medical Device Stocks
Vivos Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.